Proto Labs, Inc.
General ticker "PRLB" information:
- Sector: Industrials
- Industry: Manufacturing - Metal Fabrication
- Capitalization: $1.0B (TTM average)
Proto Labs, Inc. closely follows the US Stock Market performance with the rate: 75.7%.
Estimated limits based on current volatility of 1.4%: low 53.94$, high 55.47$
Factors to consider:
- Total employees count: 2357 as of 2024
- US accounted for 79.3% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Market competition, Economic downturns and volatility, Cybersecurity threats, Geopolitical risks, Market disruptions
- Current price 33.8% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [27.29$, 44.13$]
- 2025-12-31 to 2026-12-31 estimated range: [24.74$, 40.92$]
Financial Metrics affecting the PRLB estimates:
- Negative: with PPE of 24.6 at the end of fiscal year the price was high
- Positive: -5.02 < Operating profit margin, % of 3.98
- Positive: 6.63 < Operating cash flow per share per price, % of 7.73
- Positive: 5.42 < Industry operating cash flow per share per price (median), % of 9.63
- Positive: -4.41 < Investing cash flow per share per price, % of -1.35
- Positive: Shareholder equity ratio, % of 90.13 > 64.17
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.18
- Positive: Industry inventory ratio change (median), % of -2.84 <= -0.18
- Positive: 0.07 < Industry earnings per price (median), % of 3.87
Short-term PRLB quotes
Long-term PRLB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $488.40MM | $503.88MM | $500.89MM |
| Operating Expenses | $586.38MM | $475.71MM | $480.98MM |
| Operating Income | $-97.98MM | $28.17MM | $19.91MM |
| Non-Operating Income | $0.11MM | $-0.21MM | $4.76MM |
| R&D Expense | $38.22MM | $40.13MM | $41.30MM |
| Income(Loss) | $-97.88MM | $27.95MM | $24.67MM |
| Taxes | $5.58MM | $10.73MM | $8.08MM |
| Profit(Loss)* | $-103.46MM | $17.22MM | $16.59MM |
| Stockholders Equity | $697.65MM | $695.29MM | $670.15MM |
| Inventory | $13.58MM | $13.66MM | $12.30MM |
| Assets | $802.17MM | $772.35MM | $743.51MM |
| Operating Cash Flow | $62.08MM | $73.27MM | $77.83MM |
| Capital expenditure | $21.69MM | $28.12MM | $9.17MM |
| Investing Cash Flow | $-43.09MM | $-4.55MM | $-13.58MM |
| Financing Cash Flow | $-27.92MM | $-41.86MM | $-58.55MM |
| Earnings Per Share** | $-3.77 | $0.66 | $0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.